GSEA results revealed that the obtained RGL2 signature highly correlated with the activation of the Wnt/β-catenin pathway and EMT progression in the enrolled TCGA CRC samples (Figure 5C,D). This evidence concerns the gene RGL2 and colorectal carcinoma.